Cite
MLA Citation
K.B. Gordon et al.. “Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study.” Journal of the European Academy of Dermatology and Venereology, vol. 32, 2018, pp. 1940–1949. http://access.bl.uk/ark:/81055/vdc_100070816092.0x000038